To assess whether Arntl2 expression affects phenotypes related to tumor burden as well as metastasis in vivo, Arntl2 expression was knocked down in the 4T1 mouse mammary cell line using five shRNA constructs against murine Arntl2 (Fig 2A). This evidence concerns the gene BMAL2 and neoplasm.